← Back to Clinical Trials
Recruiting NCT03923101

The Homburg Keratoconus Center (HKC)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Keratoconus
Sponsor Universität des Saarlandes
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2011-01-01
Completion 2032-01-01
Interventions
Topographic, tomographic and biomechanical analysis.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Aim of this study is to conduct longitudinal and cross-sectional analyses about the corneal ectatic disease Keratoconus based on data obtained from Keratoconus patients in the Homburg Keratoconus Center (HKC). The Homburg Keratoconus Center (HKC) was founded in 2010 and, up to now, comprises more than 3,000 Keratoconus patients. Topographic, tomographic and biomechanic characteristics of the disease are being analyzed with the intention to elucidate how the disease begins and develops during lifetime.

Eligibility Criteria

Inclusion Criteria: * All Keratoconus patients presenting in the department of ophthalmology, Saarland University Medical Center, Homburg, Saarland, Germany. Exclusion Criteria: * Patients without Keratoconus.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE KERATOCONUS TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}